Patents Assigned to King Faisal University
  • Patent number: 12030034
    Abstract: A multi-layered oil sorbent formed from two superposed polyolefin thin films and a polypropylene (PP) fibrous thin sheet sandwiched between the two superposed polyolefin thin films. Each of the two superposed polyolefin thin films include a plurality of pores defined therethrough and a plurality of swellable cavities extending from a surface thereof. In an embodiment, the cavities of each two superposed polyolefin thin films extend from a respective polyolefin film surface toward the PP fibrous thin sheet. The two superposed polyolefin thin films with the PP fibrous thin sheet sandwiched therebetween are sealed together by a zigzag-shaped heat seal. The plurality of cavities on the surface of the multi-layered sorbent can swell when contacted with oil. The cavities coupled with the zigzag-shaped seal maximize the available volume for uptake of oil and organic pollutants from water.
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: July 9, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Junaid Saleem, Sk Safdar Hossain, Zubair Khalid Baig Moghal, Gordon McKay
  • Patent number: 12023954
    Abstract: The combination marker and eraser includes both a marker, such as those used with erasable whiteboards and markerboards, for example, and an eraser for the marker combined in a single writing implement. The combination marker and eraser includes the marker and a hollow housing. The body of the marker is received within the hollow housing such that the writing tip of the marker is positioned exterior to the hollow housing. A strip of eraser material is attached to an exterior surface of the hollow housing. The combination marker and eraser further includes an outer shell rotatably mounted about the hollow housing. The outer shell has a slot formed therethrough such that rotation of the outer shell with respect to the hollow housing selectively either covers the strip of eraser material or exposes the strip of eraser material through the slot.
    Type: Grant
    Filed: December 6, 2023
    Date of Patent: July 2, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Ibrahim Abdullah Alkhateeb, Abdullah Mohammed Aladsani, Fahad Ahmed M. Alnaim
  • Patent number: 12024518
    Abstract: Novel pyrazolo[4,3-c][1,6]naphthyridine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrazolo[4,3-c][1,6]naphthyridine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: December 20, 2023
    Date of Patent: July 2, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Christophe Tratrat, Michelyne Haroun
  • Patent number: 12026449
    Abstract: A document storage system includes a document digitizing device making an electronic copy of a document. A Liquid neural network (LNN) annotates the video files with document terms producing an annotated document. A semantic analyzer generates a relationship between document terms. A blockchain based data transaction forwards the annotated document to a server. A photonic spiking neural network (PSNN) server uploads and downloads annotated documents from the server. The interface will be changed automatically based on the individual's physical characteristics.
    Type: Grant
    Filed: January 5, 2024
    Date of Patent: July 2, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Abdul Rahaman Wahab Sait, Ibrahim Ali Albin Hamad, Yossef Ali Altriki
  • Patent number: 12023660
    Abstract: A method of forming TiO2—ZnO nanoparticles coated by a copper (II) complex includes forming a mononuclear copper complex by treating a ligand with Cu2+ ions; and immobilizing the mononuclear copper complex on TiO2—ZnO nanoparticles to obtain the TiO2—ZnO nanoparticle coated by the copper (II) complex. The TiO2—ZnO nanoparticles coated by a copper (II) complex thus produced have improved catalytic effectiveness and increased efficiency by reducing catalytic reaction time and temperature, particularly in methods of catalyzing oxidation of an alcohol or of catalyzing decarboxylative bromination of an acid.
    Type: Grant
    Filed: December 8, 2023
    Date of Patent: July 2, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Mohamed Shaker Sayed Adam, Amel Musa Taha, Mohamed M. Makhlouf
  • Patent number: 12017976
    Abstract: Synthesis of a compound 1-(4-carbonoimidoylphenoxy)-3-{4-[(E)-(phenylimino)methyl]phenoxy}propan-2-ol and its use as an insecticidal agent.
    Type: Grant
    Filed: January 4, 2024
    Date of Patent: June 25, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Mai Mostafa Khalaf Ali, Hany Mohamed Abd El-Lateef Ahmed, Mohamed Gouda, Antar Ahmed Abdelhamid Ahmed, Mohamed A. Gad
  • Patent number: 12020915
    Abstract: An etch process performed during semiconductor processing is monitored using a resonant structure on a surface of a wafer, formed on the surface of a wafer as a resonant cavity. A resonance sensor is positioned over the wafer within a plasma etch chamber so as to establish a resonance with the resonant structure. A resonant frequency of the resonant structure is sensed through the resonant structure and shifts in the resonant frequency are thereby detected during an etch process as a measurement of the etch process. The etch process is controlled in accordance with the shift in the resonant frequency.
    Type: Grant
    Filed: January 16, 2024
    Date of Patent: June 25, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventor: Hesham Mohammed Enshasy
  • Patent number: 12018026
    Abstract: Novel pyrido[4,3-e] [1,2,3]triazolo[1,5-a]pyrimidine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrido[4,3-e] [1,2,3]triazolo[1,5-a]pyrimidine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: January 10, 2024
    Date of Patent: June 25, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Michelyne Haroun, Christophe Tratrat
  • Patent number: 12017999
    Abstract: A 1-[4,5-bis(4-chlorophenyl)-1-hexyl-1H-imidazol-2-yl]-2-naphthol compound, its synthesis, and its use as an antimicrobial agent.
    Type: Grant
    Filed: November 7, 2023
    Date of Patent: June 25, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed
  • Patent number: 12018028
    Abstract: Novel 5-substituted aminopyrazino[2?,1?:2,3]imidazo[4,5-c][2,7]naphthyridine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The 5-substituted aminopyrazino[2?,1?:2,3]imidazo[4,5-c][2,7]naphthyridine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: November 10, 2023
    Date of Patent: June 25, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Michelyne Haroun, Christophe Tratrat
  • Patent number: 12017998
    Abstract: An 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid compound, its synthesis, and its use as an antimicrobial agent.
    Type: Grant
    Filed: February 8, 2024
    Date of Patent: June 25, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed, Amer A. Amer
  • Patent number: 12012385
    Abstract: A 4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole compound, its synthesis, and its use as an antimicrobial agent.
    Type: Grant
    Filed: December 12, 2023
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Mai Mostafa Khalaf Ali, Hany Mohamed Abd El-Lateef Ahmed, Ibrahim Abdelhamid Mohamed Elshaer, Antar Ahmed Abdelhamid Ahmed
  • Patent number: 12011001
    Abstract: A gold nanoparticle composition for controlling or inhibiting the growth of red palm weevil. The gold nanoparticle composition can include Peperomia blanda gold nanoparticles (PB-AuNPs) either alone or in combination with a separate extract of Peperomia blanda (PB), thereby forming PB-AuNPs. In an embodiment, the PB-AuNPs/PB can be applied to soil to protect a date palm plant growing therein from red palm weevil.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Basem Mohamed Abdallah, Enas Mohamed Ali, Salaheldin Abdelraouf Abdelsalam
  • Patent number: 12012407
    Abstract: Novel pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-3-carboxylic acid compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-3-carboxylic acid compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: January 31, 2024
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Christophe Tratrat, Michelyne Haroun
  • Patent number: 12012391
    Abstract: A 9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione compound, its synthesis, and its use as an antimicrobial agent.
    Type: Grant
    Filed: February 7, 2024
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed
  • Patent number: 12011473
    Abstract: A composition of green biosynthesized silver nanoparticles made using leaf extract of Desmidorchis retrospiciens, as a novel antifungal therapy. These biosynthesized silver nanoparticles can be combined with leaf extract of Desmidorchis retrospiciens to provide a synergistic treatment for histoplasmosis.
    Type: Grant
    Filed: November 16, 2023
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Enas Mohamed Ali Abd-Elkader, Basem Mohamed Abdallah
  • Patent number: 12012388
    Abstract: A 4-chloro-N?-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound, its synthesis, and its use as an antimicrobial agent.
    Type: Grant
    Filed: February 2, 2024
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed, Amer A. Amer
  • Patent number: 12012414
    Abstract: Novel imidazo[1,5-a]pyrido[4,3-e]pyrimidine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The imidazo[1,5-a]pyrido[4,3-e]pyrimidine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: January 4, 2024
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Christophe Tratrat, Michelyne Haroun
  • Patent number: 12012406
    Abstract: Novel pyrido[4,3-e]pyrrolo[1,2-a]pyrimidine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrido[4,3-e]pyrrolo[1,2-a]pyrimidine compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for treating other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and other types of diseases such as diabetes, viral infection, neurodegenerative diseases.
    Type: Grant
    Filed: January 11, 2024
    Date of Patent: June 18, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Michelyne Haroun, Christophe Tratrat
  • Patent number: 12006293
    Abstract: Diselenide organo compounds, their synthesis, and their use as deubiquitination signaling pathway modulators and anti-cancer agents.
    Type: Grant
    Filed: December 19, 2023
    Date of Patent: June 11, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Saad Shaaban, Amr Negm